Takuya Nishinakagawa
Overview
Explore the profile of Takuya Nishinakagawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishinakagawa T, Homma T, Ikeda A, Hazekawa M, Morita Y, Nakagaki T, et al.
Biochem Biophys Res Commun
. 2024 Oct;
735:150807.
PMID: 39413610
Cellular prion protein (PrP) is a glycosylphosphatidylinositol (GPI)-anchored cell-surface protein. The mature cell-surface PrP is internalized and subsequently degraded by lysosomes. Although, proteasomes are proposed to be involved, the precise...
2.
Nishinakagawa T, Hazekawa M, Hosokawa M, Ishibashi D
Mol Med Rep
. 2023 Feb;
27(3).
PMID: 36734265
Receptor‑binding cancer antigen expressed on SiSo cells (RCAS1) is a tumor‑associated antigen that is expressed in a number of human malignancies. RCAS1 acts as a ligand for a putative RCAS1...
3.
Hazekawa M, Nishinakagawa T, Hosokawa M, Ishibashi D
Pharmaceutics
. 2022 Apr;
14(4).
PMID: 35456649
Exosomes are nano-sized extracellular vesicles that are known to carry various messages to distant cells. It was recently reported that cancer-derived exosomes are orientated to metastatic organs. However, there are...
4.
Kawakubo-Yasukochi T, Yano E, Kimura S, Nishinakagawa T, Mizokami A, Hayashi Y, et al.
Mol Metab
. 2021 Oct;
54:101360.
PMID: 34673295
Objective: Accumulating evidence indicates that an adverse perinatal environment contributes to a higher risk of metabolic disorders in the later life of the offspring. However, the underlying molecular mechanisms remain...
5.
Hazekawa M, Nishinakagawa T, Mori T, Yoshida M, Uchida T, Ishibashi D
Sci Rep
. 2021 Aug;
11(1):16789.
PMID: 34408228
Small interfering RNAs (siRNAs) are susceptible to nucleases and degrade quickly in vivo. Moreover, siRNAs demonstrate poor cellular uptake and cannot cross the cell membrane because of its polyanionic characteristics....
6.
Mori T, Hazekawa M, Yoshida M, Nishinakagawa T, Uchida T, Ishibashi D
Int J Pharm
. 2021 Jul;
606:120891.
PMID: 34324984
LL-37, a well-known antimicrobial human peptide, is a cationic peptide that provides an important antimicrobial defense mechanism in damaged skin. Accumulating evidence indicates that LL-37 also displays an anticancer effect...
7.
Morioka M, Kawakubo-Yasukochi T, Hayashi Y, Hazekawa M, Nishinakagawa T, Ono K, et al.
J Oral Biosci
. 2020 Jun;
58(4):180-184.
PMID: 32512687
Oral squamous cell carcinoma (OSCC) is often associated with lymphatic rather than hematogenous metastasis; however, a determinant factor for this process has not been elucidated. This study examined the effect...
8.
Hazekawa M, Nishinakagawa T, Kawakubo-Yasukochi T, Nakashima M
Exp Ther Med
. 2019 Sep;
18(4):3197-3205.
PMID: 31555392
A real-time cell-monitoring analysis (RTCA) system was previously developed based on the change in impedance when cells attach and spread in a culture dish coated with a gold microelectrode array....
9.
Kawakubo-Yasukochi T, Morioka M, Ohe K, Yasukochi A, Ozaki Y, Hazekawa M, et al.
J Dev Orig Health Dis
. 2019 May;
10(6):683-691.
PMID: 31131784
Gestational nutrition is widely recognized to affect an offspring's future risk of lifestyle-related diseases, suggesting the involvement of epigenetic mechanisms. As folic acid (FA) is a nutrient essential for modulating...
10.
Yasukochi A, Kawakubo-Yasukochi T, Morioka M, Hazekawa M, Nishinakagawa T, Ono K, et al.
J Biochem
. 2019 Mar;
166(2):163-173.
PMID: 30918974
Collagen type XVII (COL17) is expressed in various tissues and its aberrant expression is associated with tumour progression. In this study, we investigated the regulation of COL17 expression in oral...